1 ALZHEIMER'S DISEASE [READ MORE] 2 PARKINSONS'S DISEASE [READ MORE]

Science

Video: Understanding CERE-110 for Alzheimer's Video: Understanding CERE-120 for Parkinson's

Quick Links: Science at Ceregene » Neurotrophic Factors » Gene Delivery Technology »

Newsroom

04-19-13: Ceregene Reports Data From Parkinson's Disease Phase 2b Study »
03-13-13: Ceregene and Alzheimer's Disease Cooperative Study Group Complete
Enrollment of CERE-110 Phase 2 Trial »
05-17-12: Ceregene Parkinson's Disease Study Demonstrates Long-term Neurturin Expression
and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin) »

Developing treatments for Parkinson's
and Alzheimer's diseases using
the combined power of neurotrophic
factors and gene therapy.